Sandra Ballester
Overview
Explore the profile of Sandra Ballester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perez-Ubeda M, Arribas P, Garcia-Andrade M, Garvin L, Rodriguez A, Ponz V, et al.
Arthroscopy
. 2023 Jul;
40(2):305-317.
PMID: 37394147
Purpose: To evaluate the outcomes of adding arthroscopy to osteosynthesis of distal radius fractures (DRF) with volar locking plate (VLP), by Patient-Rated Wrist Evaluation (PRWE) 1 year after surgery. Methods:...
2.
Ballester S, Pineda B, Rodrigues P, Tormo E, Terol M, Eroles P
Genes (Basel)
. 2020 Jun;
11(6).
PMID: 32585853
Angiogenesis process contributes to the pathogenesis of B-cell chronic lymphocytic leukemia (B-CLL) being the levels of VEGFA and bFGF higher in patients than in healthy controls. Our aim was to...
3.
Tormo E, Ballester S, Adam-Artigues A, Burgues O, Alonso E, Bermejo B, et al.
Sci Rep
. 2019 Mar;
9(1):5316.
PMID: 30926829
The mechanisms of chemotherapy resistance in triple negative breast cancer remain unclear, and so, new molecules which might mediate this resistance could optimize treatment response. Here we analyzed the involvement...
4.
Tormo E, Adam-Artigues A, Ballester S, Pineda B, Zazo S, Gonzalez-Alonso P, et al.
Sci Rep
. 2017 Jan;
7:41309.
PMID: 28120942
A subset of HER2+ breast cancer patients manifest clinical resistance to trastuzumab. Recently, miR-26a and miR-30b have been identified as trastuzumab response regulators, and their target gene CCNE2 seems to...
5.
Rodrigues P, Furriol J, Tormo E, Ballester S, Lluch A, Eroles P
Mol Cell Biochem
. 2013 May;
379(1-2):181-90.
PMID: 23716179
The tumour-suppressor gene TP53 has been associated with the angiogenic pathway by a TP53 response element sequence of the VEGFR1 promoter. Within that sequence, the polymorphism -710 C/T VEGFR1, which...
6.
Rodrigues P, Furriol J, Tormo E, Ballester S, Lluch A, Eroles P
Breast Cancer Res Treat
. 2012 Feb;
133(2):769-78.
PMID: 22315135
Vascular endothelial growth factor (VEGF) is a potent regulator of angiogenesis and thereby involved in the development and progression of solid tumours. The association between polymorphisms of angiogenesis pathway genes...
7.
Barragan E, Pajuelo J, Ballester S, Fuster O, Cervera J, Moscardo F, et al.
Clin Chim Acta
. 2008 Jul;
395(1-2):120-3.
PMID: 18590714
Background: Molecular analysis of minimal residual disease is only applicable in acute myeloblastic leukemia (AML) patients with genetic markers (20-30%). This study analyzes the feasibility of the real-time quantitative polymerase...
8.
Barragan E, Cervera J, Bolufer P, Ballester S, Martin G, Fernandez P, et al.
Haematologica
. 2004 Sep;
89(8):926-33.
PMID: 15339675
Background And Objectives: The Wilms' tumor (WT1) gene is overexpressed in patients with most forms of acute leukemia. Several studies have reported the usefulness of quantitative assessment of WT1 expression...